Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1553649

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1553649

UK Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report by Product (System, Consumables), By Modality (Slow Continuous Ultra Filtration, Continuous Venovenous Hemofiltration), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 300 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

UK Continuous Renal Replacement Therapy Market Growth & Trends:

The UK continuous renal replacement therapy market size is anticipated to reach USD 131.7 million by 2030 and is anticipated to expand at a CAGR of 9.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by numerous factors such as technological advancements such as innovations in design, materials, and manufacturing processes. These advancements have improved the safety, efficiency, and efficacy of CRRT treatments.

One of the most significant advancements in CRRT technology is the development of faster and more efficient filtration systems. New membrane technologies, such as hollow-fiber membranes and nanofiltration, have increased filtration rates and reduced treatment time. This means that patients can receive more effective treatment while minimizing the risk of complications like hemolysis and bleeding. Further, new tubing materials, such as heparin-coated lines, have minimized blood trauma and reduced the risk of complications like hemolysis. This is particularly important in patients with compromised blood vessels or those who are at risk of bleeding.

Moreover, key manufacturers in the industry are prioritizing the development and implementation of digital technologies to enhance knowledge of CRRT among healthcare professionals. For instance, in March 2024 Fresenius Medical Care recently launched an innovative Augmented Reality (AR) application. This cutting-edge technology enables nursing staff to learn Kidney Replacement Therapy in Intensive Care Units more effectively. The AR glasses, paired with digital learning modules, allow nursing staff to gain hands-on experience with acute dialysis machines directly within the intensive care wards. As users interact with the machines, the glasses stream visual and acoustic recordings, providing a comprehensive and immersive learning experience for healthcare professionals.

UK Continuous Renal Replacement Therapy Market Report Highlights:

  • The consumables segment dominated the market and accounted for a revenue share of 60.40% in 2023. On the other hand, the consumables segment is expected to register the fastest CAGR during the forecast period owing to growing demand for continuous renal replacement therapy (CRRT) and rising awareness of CRRT benefits.
  • The Continuous Venovenous Hemofiltration (CVVH) segment dominated the market and is also expected to register the fastest CAGR of 10.2% during the forecast period. Manufacturers are providing clinical education and training to healthcare professionals on the use of CVVH technology, which is helping to increase adoption and utilization.
  • England segment dominated the market in 2023 owing to growing cases of AKI. For instance, according to The Renal Association report published in 2023, in 2022, the rate of AKI episodes per million population was 12,651, compared to 11,660 in 2018.
  • Baxter, B. Braun Medical Ltd, Medtronic, Fresenius Medical Care UK Ltd, Braun & Co. Limited, Medica Advanced Technologies Ltd, and NIKKISO UK Co. Ltd. are the key players in the UK Continuous Renal Replacement Therapy (CRRT) market.
Product Code: GVR-4-68040-434-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. UK Continuous Renal Replacement Therapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Acute Kidney Injury (Aki)
      • 3.2.1.2. Rising Awareness of The Importance of Early Treatment
      • 3.2.1.3. Growing Adoption of CRRT In ICUs
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Rising Costs of CRRT Treatment
      • 3.2.2.2. Competition From Alternative Therapies
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Growing Development of Next-Generation CRRT Devices
  • 3.3. UK Continuous Renal Replacement Therapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. UK Continuous Renal Replacement Therapy Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. UK Continuous Renal Replacement Therapy Market Product Movement Analysis
  • 4.3. UK Continuous Renal Replacement Therapy Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. System
    • 4.4.1. System UK Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables UK Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. UK Continuous Renal Replacement Therapy Market: Modality Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. UK Continuous Renal Replacement Therapy Market Modality Movement Analysis
  • 5.3. UK Continuous Renal Replacement Therapy Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 5.4. Slow Continuous Ultra Filtration (SCUF)
    • 5.4.1. Slow Continuous Ultra Filtration (SCUF) Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Continuous Venovenous Hemofiltration (CVVH)
    • 5.5.1. Continuous Venovenous Hemofiltration (CVVH) Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.6.1. Continuous Venovenous Hemodialysis (CVVHD) Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Continuous Venovenous Hemodiafiltration (CVVHDF)
    • 5.7.1. Continuous Venovenous Hemodiafiltration (CVVHDF) Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. UK Continuous Renal Replacement Therapy Market: Regional Estimates & Trend Analysis by Product, By Modality

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. England
    • 6.3.1. England Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. England
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Scenario
      • 6.3.2.4. Reimbursement Scenario
      • 6.3.2.5. England Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Scotland
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Scenario
      • 6.3.3.4. Reimbursement Scenario
      • 6.3.3.5. Scotland Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Wales
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Scenario
      • 6.3.4.4. Reimbursement Scenario
      • 6.3.4.5. Wales Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Northern Ireland
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Scenario
      • 6.3.5.4. Reimbursement Scenario
      • 6.3.5.5. Northern Ireland Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Baxter
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Product Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. B. Braun Medical Ltd
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Product Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Medtronic
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Product Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Fresenius Medical Care UK Ltd
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Product Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Braun & Co. Limited
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Product Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Medica Advanced Technologies Ltd
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Product Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. NIKKISO UK Co. Ltd.
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Product Benchmarking
      • 7.2.7.4. Strategic Initiatives
  • 7.3. Heat Map Analysis/ Company Market Position Analysis
  • 7.4. Estimated Company Market Share Analysis, 2023
  • 7.5. List of Other Key Market Players
Product Code: GVR-4-68040-434-4

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. UK Continuous Renal Replacement Therapy Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. UK Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 5. UK Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
  • Table 6. England Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 7. England Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
  • Table 8. Scotland Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 9. Scotland Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
  • Table 10. Wales Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 11. Wales Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
  • Table 12. Northern Ireland Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 13. Northern Ireland Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
  • Table 14. Participant's Overview
  • Table 15. Financial Performance
  • Table 16. Product Benchmarking
  • Table 17. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 UK Continuous Renal Replacement Therapy Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Regional Marketplace: Key Takeaways
  • Fig. 13 UK Continuous Renal Replacement Therapy Market, for System, 2018 - 2030 (USD Million)
  • Fig. 14 UK Continuous Renal Replacement Therapy Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 15 UK Continuous Renal Replacement Therapy Market, for Slow Continuous Ultra Filtration (SCUF), 2018 - 2030 (USD Million)
  • Fig. 16 UK Continuous Renal Replacement Therapy Market, for Continuous Venovenous Hemofiltration (CVVH), 2018 - 2030 (USD Million)
  • Fig. 17 UK Continuous Renal Replacement Therapy Market, for Continuous Venovenous Hemodialysis (CVVHD), 2018 - 2030 (USD Million)
  • Fig. 18 UK Continuous Renal Replacement Therapy Market, for Continuous Venovenous Hemodiafiltration (CVVHDF), 2018 - 2030 (USD Million)
  • Fig. 19 Regional Outlook, 2023 & 2030
  • Fig. 20 England Continuous Renal Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 21 Scotland Continuous Renal Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 22 Wales Continuous Renal Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 23 Northern Ireland Continuous Renal Replacement Therapy Market, 2018 - 2030 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!